ABSTRACT
Rhodococcus equi is a respiratory pathogen which primarily infects foals and is endemic on farms around the world with 50% mortality and 80% morbidity in affected foals. Unless detected early and treated appropriately the disease can be fatal. Currently, there is no vaccine available to prevent this disease. For decades researchers have endeavoured to develop an effective vaccine to no avail. In this study a novel human adenoviral vector vaccine for R. equi was developed and tested in the mouse model. This vaccine generated a strong antibody and cytokine response and clearance of R. equi was demonstrated following challenge. These results show that this vaccine could potentially be developed further for use as a vaccine to prevent R. equi disease in foals.
Subject(s)
Actinomycetales Infections/veterinary , Bacterial Vaccines/therapeutic use , Horse Diseases/prevention & control , Rhodococcus equi/immunology , Actinomycetales Infections/prevention & control , Animals , Antibodies, Bacterial/immunology , Bacterial Vaccines/immunology , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Horse Diseases/microbiology , Horses , Lung/cytology , Lung/metabolism , Lung/microbiology , Mice , Mice, Inbred C3HABSTRACT
Resistance to antimicrobials in enterococci from poultry has been found throughout the world and is generally recognized as associated with antimicrobial use. This study was conducted to evaluate the phenotypic and genotypic profile of enterococcal isolates of intensive (indoor) and free range chickens from 2008/09 and 2000 in order to determine the patterns of antimicrobial resistance associated with different management systems. The minimum inhibitory concentrations in faecal enterococci isolates were determined by agar dilution. Resistance to bacitracin, ceftiofur, erythromycin, lincomycin, tylosin and tetracycline was more common among meat chickens (free range and intensive) than free range egg layers (P<0.05). Isolates were evaluated by polymerase chain reaction for bacitracin (bcrR), tylosin (ermB), tetracycline (tet(L), tet(M), tet(O), tet(S), and tet(K)), gentamicin (aac6-aph2), vancomycin (vanC and vanC2), ampicillin (pbp5) and integrase (int) genes. Resistance to bacitracin, erythromycin and tetracycline were found to be correlated with the presence of bcrR, ermB, and tet genes in most of the isolates collected from meat chickens. Most bacteria encoding ermB gene were found to express cross-resistance to erythromycin, tylosin and lincomycin. No significant difference was found in these resistance genes between isolates sampled in 2000 and 2008/09 (P<0.5). Unlike the enterococcal strains sampled in 2000, the 2008/09 isolates were found to be susceptible to vancomycin and virginiamycin. This study provides evidence that, despite strict regulation imposed on antibiotic usage in poultry farming in Australia, antimicrobial resistance is present in intensively raised and free range meat chickens.
Subject(s)
Anti-Infective Agents/pharmacology , Chickens/microbiology , Drug Resistance, Bacterial/genetics , Enterococcus/drug effects , Gram-Positive Bacterial Infections/veterinary , Poultry Diseases/microbiology , Animals , Base Sequence , Enterococcus/genetics , Enterococcus/isolation & purification , Feces/microbiology , Genes, Bacterial/genetics , Gram-Positive Bacterial Infections/microbiology , Microbial Sensitivity Tests/veterinary , Molecular Sequence Data , Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA , South AustraliaABSTRACT
Antibiotic use in poultry production is a risk factor for promoting the emergence of resistant Escherichia coli. To ascertain differences in different classes of chickens, the resistance profile, some virulence genes and phylogenetic grouping on 251 E. coli isolates from intensive meat (free range and indoor commercial) and free range egg layer chickens collected between December 2008 and June 2009 in South Australia were performed. Among the 251 strains, 102 (40.6%) and 67 (26.7%) were found to be resistant to tetracycline and ampicillin respectively. Resistance was also observed to trimethoprim-sulfamethoxazole (12.4%), streptomycin (10.8%), spectinomycin (9.6%), neomycin (6.0%) and florfenicol (2.0%) but no resistance was found to ceftiofur, ciprofloxacin or gentamicin. Amplification of DNA of the isolates by polymerase chain reaction revealed the presence of genes that code for resistant determinants: tetracycline (tet(A), tet(B) and tet(C)), ampicillin (bla(TEM) and bla(SHV)), trimethoprim (dhfrV and dhfrXIII), sulphonamide (sulI and sulII), neomycin (aph(3)-Ia(aphA1)), and spectinomycin-streptinomycin (aadA2). In addition, 32.3-39.4% of the isolates were found to belong to commensal groups (A and B1) and 11.2-17.1% belonged to the virulent groups (B2 and D). Among the 251 E. coli isolates, 25 (10.0%) carried two or more virulence genes typical of Extraintestinal pathogenic E. coli (ExPEC). Furthermore, 17 of the isolates with multi-resistance were identified to be groups B2 and D. Although no significant difference was observed between isolates from free range and indoor commercial meat chickens (P>0.05), significant differences was observed between the different classes of meat chickens (free range and indoor commercial) and egg layers (P<0.05). While this study assessed the presence of a limited number of virulence genes, our study re emphasises the zoonotic potential of poultry E. coli isolates.
